Wound Treatments - South Korea

May 2010 | 32 pages | ID: W860A80DD72EN
Euromonitor International Ltd

Abstracts

Wound treatments continued healthy current value growth of 2% in 2009 to reach sales of almost Won19bn, thanks mainly to the strong performance of medicated dressings under other wound treatments which do not cause any scarring after treatment, and allow enough air to penetrate during the healing process. With market expansion, more manufacturers introduced new products into the subsector and 3% current value growth saw sales reach Won11bn in 2009.

Euromonitor International's Wound Treatments Products in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Other Wound Treatments, Sticking Plasters

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health industry;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Wound Treatments in South Korea
Euromonitor International
May 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Consumer Health Shows Negative Performance in 2009
Consumer Awareness About Boosting the Immune System Increases
Pharmaceutical Companies Focus More on Rx and Non-healthcare Products
Further Delay in Expansion of OTC Healthcare Into Grocery Retail Channel
Consumer Health Expected To Post Marginal Growth Over the Forecast Period
Key Trends and Developments
H1n1 Affected Market Performance
New Product Formats and Packaging To Capture Consumer Interest
Pharmaceutical Companies Have Increasingly Diverse Business Portfolios
Expanding Distribution Into the Grocery Channel Delayed
Young Consumers Emerge As Target Market for Nutritional Products
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Penetration of Private Label by Sector 2004-2009
  Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sector and Subsector Definitions
  Summary 1 Research Sources
Daewoong Pharmaceutical Co Ltd
Strategic Direction
Key Facts
  Summary 2 Daewoong Pharmaceutical Co Ltd: Key Facts
  Summary 3 Daewoong Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
  Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics 2009
Competitive Positioning
  Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2009
Dong-a Pharmaceutical Co Ltd
Strategic Direction
Key Facts
  Summary 6 Dong-A Pharmaceutical Co Ltd: Key Facts
  Summary 7 Dong-A Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
  Summary 8 Dong-A Pharmaceutical Co Ltd: Production Statistics 2009
Competitive Positioning
  Summary 9 Dong-A Pharmaceutical Co Ltd: Competitive Position 2009
Korea Ginseng Corp
Strategic Direction
Key Facts
  Summary 10 Korea Ginseng Corp: Key Facts
  Summary 11 Korea Ginseng Corp: Operational Indicators
Company Background
Production
  Summary 12 Korea Ginseng Corp: Production Statistics 2009
Competitive Positioning
  Summary 13 Korea Ginseng Corp: Competitive Position 2009
Kwang Dong Pharm Co Ltd
Strategic Direction
Key Facts
  Summary 14 Kwang Dong Pharm Co Ltd: Key Facts
  Summary 15 Kwang Dong Pharm Co Ltd: Operational Indicators
Company Background
Production
  Summary 16 Kwang Dong Pharm Co Ltd: Production Statistics 2009
Competitive Positioning
  Summary 17 Kwang Dong Pharm Co Ltd: Competitive Position 2009
Trends
Category Data
  Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
  Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
  Table 14 Wound Treatments Company Shares by Value 2005-2009
  Table 15 Wound Treatments Brand Shares by Value 2006-2009
  Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
  Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014